Italia markets closed

BMY May 2025 62.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,7300+0,0900 (+14,06%)
Alla chiusura: 02:00PM EDT
Schermo intero
Chiusura precedente0,6400
Aperto0,6900
Denaro0,6700
Lettera1,0900
Prezzo d'esercizio62,50
Scadenza2025-05-16
Min-Max giorno0,6900 - 0,7300
Contratto - Min-MaxN/D
Volume12
Open Interest24
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri